Docusign, Inc. (NASDAQ: DOCU) reported its second quarter 2026 earnings results.
Revenue was $800.6 million, up 9% year-over-year.
Net income was $62.9 million, or $0.30 per share, compared to $888.2 million, or $4.26 per share, last year. Adjusted EPS was $0.92.
Billings were $818 million, up 13% year-over-year.
Subscription revenue was $784.4 million, up 9% year-over-year. Professional services and other revenue was $16.2 million, up 13% year-over-year.
For the third quarter of 2026, total revenue is expected to be $804-808 million.
For the full year of 2026, total revenue is expected to be $3.18-3.20 billion.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
After a rollercoaster year, is Tesla (TSLA) stock a good bet?
In recent years, Tesla's (NASDAQ: TSLA) stock has often swung between record highs and sharp corrections, reflecting shifts in investor sentiment, broader economic conditions, and changes in its financial performance.
Dollar Tree (DLTR), Dollar General (DG): Discount stores remain key gainers in a value-conscious landscape
Discount retailers Dollar Tree, Inc. (NASDAQ: DLTR) and Dollar General Corporation (NYSE: DG) have seen their stocks gain more than 30% in the past three months. The dollar stores continue
Everything you need to know about Aktis Oncology’s upcoming IPO
IPO activity in 2025 showed a marked rebound, led by the technology and healthcare sectors, after last year's sluggish performance. Aktis Oncology, which develops radiopharmaceuticals for solid tumors, is the
